BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 (BIOTW)

CUSIP: G1125A116

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / *W EXP 11/30/202
Total 13F shares
7,803,219
Share change
+1,784,347
Total reported value
$5,531,000
Price per share
$0.66
Number of holders
53
Value change
+$1,607,242
Number of buys
24
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP G1125A116?
CUSIP G1125A116 identifies BIOTW - BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 (BIOTW) as of Q4 2021

As of 31 Dec 2021, BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 (BIOTW) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,803,219 shares. The largest 10 holders included ARISTEIA CAPITAL LLC, HGC Investment Management Inc., CITADEL ADVISORS LLC, Corbin Capital Partners, L.P., RAMIUS ADVISORS LLC, Linden Advisors LP, KINGSTOWN CAPITAL MANAGEMENT L.P., Sage Rock Capital Management LP, Atalaya Capital Management LP, and Blackstone Inc. This page lists 53 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.